Search Press releases Keywords From To 8 May 2024 UCB presents final open-label extension F®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting Read More 3 May 2024 Acquisition of own shares Read More 26 Apr 2024 Acquisition of own shares Read More 25 Apr 2024 UCB’s General Meeting of Shareholders 2024 Read More 25 Apr 2024 UCB off to a Good Start into 2024 – Progressing on its Growth Path for a Decade Plus Read More 23 Apr 2024 Transparency notification FMR LLC Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
